|
News Release |
1001
Connecticut Ave, NW - Ste 710 - Washington, DC 20036 |
September 2, 1999
Swiss Government Promises Marijuana Decriminalization
Sept. 2, 1999, Switzerland:
Switzerland's marijuana
prohibition may
be
a thing of the past as government officials have promised to
decriminalize marijuana use and possession. Drug use will remain illegal
for children under 18 years of age.
A Swiss government study shows 27 percent of 15-35 year olds in the
country use cannabis.
"We remain in the lead for the innovative approaches addressing
drug-related issues," said Thomas Zeltner, director of Switzerland's
Federal Department for Health.
"The consumption of cannabis can't be avoided through prohibition,"
the
Swiss Department of the Interior said in its proposal. "We aim to adapt
legislation to reality in the area of drug consumption."
The proposal stated cannabis, "does relatively little damage to
health," and under certain circumstances "can have a therapeutic
effect."
The Swiss Government has also suggested criminal penalties for the
use
of harder drugs such as cocaine be eliminated as well. In June, voters
approved legislation to legally provide heroin to addicts if they have a
prescription.
"It's amazing to see just how isolated the United States is becoming
on
the issue of marijuana," said Allen St. Pierre, NORML Foundation
Executive Director. "While European countries and Canada are crafting
meaningful legal reforms -- reflecting modern mores in a rational public
policy -- America is increasingly relying on expanding the budgets and
power of the 'three Ps': police, prosecutors, and prisons."
For more information, please contact Allen St. Pierre NORML
Foundation
Executive Director at (202) 483-8751.
Kentucky Supreme Court To Hear Harrelson's Hemp Case in October
Sept. 2, 1999, Frankfort, KY:
Actor Woody Harrelson's
Kentucky
industrial hemp challenge will reach the state Supreme Court at 11 a.m.,
on Oct. 14, 1999 in Louisville.
The Kentucky Supreme Court will review a decision by the state
Circuit
Court of Appeals which earlier denied review of a June 1996 order by the
trial court to dismiss the case against Harrelson and declare the
legality of hemp prohibition in the state of Kentucky.
In a highly publicized event, Harrelson planted four industrial hemp
seeds in June of 1996, and was cited by state officials for marijuana
possession. The Lee County Court dismissed the charge, finding the
state law outlawing marijuana was overly broad by including industrial
hemp. The dismissal was appealed by the government in November and the
state Court of Appeals, in a purely procedural ruling, said the
prosecutor could not appeal the dismissal. Both sides have asked the
state Supreme Court to make a decision on the merits regarding the
validity of hemp prohibition.
"It's unlikely the court will go that far," said Tom Dean, Esq.,
NORML
Foundation Litigation Director. "If anything the state supreme court will
send the case back to the court of appeal for further review."
Harrelson argued that the statute outlawing marijuana possession was
unconstitutional because it does not differentiate between marijuana and
industrial hemp.
"The express purpose of these laws has been to prevent the people
from
ingesting what has been deemed a dangerous psychoactive substance," Dean
said. "Pointing out that industrial hemp is incapable of producing a
psychoactive effect, Harrelson is arguing that hemp has been
inappropriately lumped in with the drug marijuana, the intended object of
prohibition."
For more information, please contact Tom Dean, Esq., NORML Foundation
Litigation Director at (202) 483-8751 or Burl McCoy, Esq., attorney for
Woody Harrelson at (606) 254-6363.
Committee To Tell Maine Medical Association To Oppose Medical Marijuana Referendum
Sept. 2, 1999, Augusta, ME:
The public health committee of
the Maine
Medical Association will recommend that the organization opposes the
November referendum on the legalization of medical marijuana.
Included among the committee's complaints against the referendum were
that the list of diseases approved for medical use was too long, and that
marijuana was a "gateway drug leading users to frequently use stronger
illicit or harmful drugs."
"It's precisely that marijuana is so helpful for so many ailments
that
the MMA should be looking at the safety and utility of medical marijuana,
rather than adopting the federal government's 'flat earth' anti-marijuana
stance," said Allen St. Pierre, NORML Foundation Executive Director. "Further, the MMA should read the recently released Institute of Medicine
report on the health effects of marijuana.
In the IOM report researchers put to rest the myth that marijuana is
a
gateway drug."
NORML Foundation's Chair Lester Grinspoon, MD, of Harvard Medical
School will present a lecture to the MMA's annual meeting in two weeks.
"It's our hope that Dr. Grinspoon can impress upon the other
physicians
in attendance the need for them to support -- not oppose -- the current
medical marijuana law reform efforts in Maine."
For more information, please contact Allen St. Pierre, Executive
Director of NORML Foundation at (202) 483-8751 or Lester Grinspoon, MD,
NORML Foundation Chair at (617)277-3621. To view the IOM Report: http://books.nap.edu/html/marimed.
Scottish Parliament Member Submits Motion To Examine Cannabis Legalization
Sept. 2, 1999, Scotland:
A member of the Scottish
Parliament has
submitted a motion that calls for a panel of experts and citizens to
examine cannabis legalization.
Eleven additional members of Scottish Parliament are needed to
support
the motion before the first debates would begin.
"The time is right for the issue to be debated," said Margo
MacDonald,
the parliament member who initiated the motion. "It's nothing to do with
political parties, and I hope it will be discussed before Christmas."
MacDonald is a former member of the Scotland Against Drugs
organization
but said she left after the group passed up the chance to change things
when the Church of Scotland's social committee suggested a Royal
Commission on the issue of cannabis.
"This is hopefully another promising step in the succession of
cannabis
decriminalization in Europe," said Scott Colvin, Publications Director of
NORML.
For more information, please contact Scott Colvin, Publications
Director of NORML at (202) 483-5500.
-END-